Skip to main content
Log in

Decreased levels of an inhibitor of prostaglandin E 9-ketoreductase activity in chick dystrophic breast muscle

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

A WIDE range of membrane anomalies is one of the characteristics of dystrophic muscle1,2. Since prostaglandins (PGs) are known to interact with such membrane constituents as adenyl and guanyl cyclase; Mg2+-dependent, Na+/K+-activated ATPase; Mg2+-dependent, Ca2+-activated ATPase; adenylate kinase; and phosphodiesterase3, it seemed desirable to search for a possible relationship between PGs and the dystrophic condition. The activities of two potentially regulatory PG-metabolising enzymes were measured. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activities4 in the breast muscles of 10-d post-hatching chicks with hereditary muscular dystrophy (New Hampshire strain) and the breast muscles of 10-d post-hatching normal (white leghorn) chicks were the same as those in the leg muscles of these animals. PGE 9-ketoreductase activity5,6 in the dystrophic breast muscle was considerably more active than its control (normal) breast muscle. Subsequently, it was found that the normal breast muscle contains a much higher level of an inhibitor of PGE 9-ketoreductase activity than dystrophic breast muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rodan, S. B., Hintz, R. L., Sha'afi, R. I., and Rodan, G. A., Nature, 252, 589–591 (1974).

    Article  ADS  CAS  Google Scholar 

  2. Roses, A. D., Herbstreith, M. H., and Appel, S. H., Nature, 254, 350–351 (1975).

    Article  ADS  CAS  Google Scholar 

  3. Ramwell, P. W., and Kury, P., in Prostaglandins 1973, 43–54 (INSERM, Paris, 1973).

    Google Scholar 

  4. Anggard, E., and Samuelsson, B., Ark. Kemi., 25, 293–300 (1966).

    CAS  Google Scholar 

  5. Lee, S. C., and Levine, L., J. biol. Chem., 249, 1369–1375 (1974); Lee, S. C., and Levine, L., J. biol. Chem., 250, 4549–4555 (1975).

    CAS  PubMed  Google Scholar 

  6. Hensby, C. N., Biochim. biophys. Acta, 348, 145–154 (1974).

    Article  CAS  Google Scholar 

  7. Milhorat, A. T. (ed.), Exploratory Concepts in Muscular Dystrophy and Related Disorders (Excerpta Medica Foundation, International Congress Series No. 147, 1967); Exploratory Concepts in Muscular Dystrophy II (Excerpta Medica Foundation, International Congress Series No. 333, Amsterdam, American Elsevier, New York, 1974).

  8. Cosmos, E., Devl Biol., 13, 163–181 (1966).

    Article  CAS  Google Scholar 

  9. Pace-Asciak, C., and Miller, D., Prostaglandins, 4, 351–362 (1973).

    Article  CAS  Google Scholar 

  10. Pace-Asciak, C., J. biol. Chem., 250, 2789–2794 (1975); Pace-Asciak, C., J. biol. Chem., 250, 2795–2800 (1975).

    CAS  PubMed  Google Scholar 

  11. West, W. T., in Man and Animals (edit. by Bourne, G. H., and Golarz, M. N.), 367 (Hafner, New York, 1967).

    Google Scholar 

  12. Zalkin, H., et al., J. biol. Chem., 237, 2678–2682 (1962).

    CAS  PubMed  Google Scholar 

  13. Chow, T., et al., J. clin. Invest., 56, 842–849 (1975).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LEVINE, L., Wu, KY. & HERRMANN, H. Decreased levels of an inhibitor of prostaglandin E 9-ketoreductase activity in chick dystrophic breast muscle. Nature 260, 791–793 (1976). https://doi.org/10.1038/260791a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/260791a0

  • Springer Nature Limited

This article is cited by

Navigation